Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

Full description

Bibliographic Details
Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Subjects:	angiotensin receptor blockers angiotensin‐converting enzyme inhibitors calcium channel blockers COVID‐19 renin‐aldosterone angiotensin system inhibitors thiazide diuretics
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.025289

Similar Items

Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
by: Ioanna Koniari, et al.
Published: (2023-04-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
by: Fabrizio Buffolo, et al.
Published: (2021-05-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
by: Piotr Skonieczny, et al.
Published: (2021-06-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
by: S. G. Kanorskiy
Published: (2021-04-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
by: Mishita Goel, et al.
Published: (2020-08-01)

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
by: Melissa Y. Y. Moey, et al.
Published: (2019-07-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Impact of Renin‐Angiotensin System Inhibitors on Long‐Term Clinical Outcomes of Patients With Coronary Artery Spasm
by: Byoung Geol Choi, et al.
Published: (2016-07-01)

The dual blockade of the renin-angiotensin system in Internal Medicine: after ONTARGET trial
by: F. Rondoni, et al.
Published: (2013-05-01)

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
by: Juan Meng, et al.
Published: (2020-01-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Pharmacotherapy for Essential Hypertension: A Brief Review
by: Behnam Heidari, et al.
Published: (2022-12-01)

Chronic Prescription of Renin-Angiotensin-Aldosterone System Inhibitors and Hospital Outcomes in Patients with Hypertension and COVID-19
by: De Oliveira KA, et al.
Published: (2025-10-01)

Acquisition of renin-angiotensin-aldosterone system inhibitors for the treatment of cardiovascular diseases in regions of the Far Eastern Federal District
by: M. S. Soboleva, et al.
Published: (2020-04-01)

The evolutionary development of the renin angiotensin aldosterone system and its importance for the survival of the human species
by: Natalia Butt-Hussaim, et al.
Published: (2021-03-01)

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review
by: Saeed Alshahrani
Published: (2023-02-01)

Stopping versus continuing renin-angiotensin system inhibitors before surgery: An updated systematic review and meta-analysis of randomised controlled trials
by: Marwah Algodi, et al.
Published: (2025-10-01)

Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
by: Sonali R. Gnanenthiran, et al.
Published: (2022-09-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-07-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
by: Annina S. Vischer, et al.
Published: (2021-03-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
by: Tao Liu, et al.
Published: (2023-01-01)

Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies
by: Ruchika Sharma, et al.
Published: (2022-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
by: N. A. Morina, et al.
Published: (2017-11-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
by: Kamryn E. Jones, et al.
Published: (2024-06-01)

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
by: Agnese Valentini, et al.
Published: (2025-08-01)

Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/Indapamide, and Telmisartan/Amlodipine/Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiovascular Risk: A Real-world Observational Study
by: Shambo Samrat Samajdar, et al.
Published: (2023-01-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
by: O. K. Vikulova, et al.
Published: (2020-08-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Angiotensin Converting Enzyme Inhibitor Has a Protective Effect on Decompression Sickness in Rats
by: Aleksandra Mazur, et al.
Published: (2018-03-01)

Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
by: Miyeon Kim, et al.
Published: (2025-05-01)